化学科研者一站式服务平台
化合物简介
Azilsartan medoxomil is a long-acting angiotensin II receptor blocker (ARB) that is used to lower hypertension. When Azilsartan medoxomil enters the gastrointestinal tract, it is rapidly converted to its active form, Azilsartan.
基本信息
CAS:863031-21-4
中文别名:阿齐沙坦酯;阿奇沙坦酯;1-[[2’-(2,5-二氢-5-氧代-1,2,4-恶二唑-3-基)[1,1’-联苯]-4-基]甲基]-2-乙氧基-1H-苯并咪唑-7-羧酸 (5-甲基-2-氧代-1,3-二恶茂-4-基)甲酯;
英文别名:(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester of 1-[[2\'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1\'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid;Azilsartan (medoxomil);Azilsartan Medoxomil;Azilsartan kamedoxomil;(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-(5-oxo-2H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate;TAK 491;Azilsartan;[14C]-Azilsartan medoxomil;(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2\'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate;UNII-LL0G25K7I2;azilsartanum medoxomilum;Edarbi;
分子式:C30H24N4O8
分子量:568.534
精确质量:568.159
Psa:155.59
Logp:4.7052
中文别名:阿齐沙坦酯;阿奇沙坦酯;1-[[2’-(2,5-二氢-5-氧代-1,2,4-恶二唑-3-基)[1,1’-联苯]-4-基]甲基]-2-乙氧基-1H-苯并咪唑-7-羧酸 (5-甲基-2-氧代-1,3-二恶茂-4-基)甲酯;
英文别名:(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester of 1-[[2\'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1\'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid;Azilsartan (medoxomil);Azilsartan Medoxomil;Azilsartan kamedoxomil;(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-(5-oxo-2H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate;TAK 491;Azilsartan;[14C]-Azilsartan medoxomil;(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2\'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate;UNII-LL0G25K7I2;azilsartanum medoxomilum;Edarbi;
分子式:C30H24N4O8
分子量:568.534
精确质量:568.159
Psa:155.59
Logp:4.7052
编号系统
MDL号:MFCD22199532
物化性质
密度:1.45
安全信息
生产方法及用途
用途
治疗高血压症的血管紧张素II受体拮抗剂药物,多用于治疗高血压症,也是目前唯一处于末期临床的血管紧张素II受体拮抗剂(沙坦类)药物。
治疗高血压症的血管紧张素II受体拮抗剂药物,多用于治疗高血压症,也是目前唯一处于末期临床的血管紧张素II受体拮抗剂(沙坦类)药物。
合成路线
上游原料
下游产品
图谱
13C NMR : Predict

1H NMR : Predict
